Literature DB >> 30105418

Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.

Hong-Kui Yu1, Bei Xia2, Xiao Liu1, Chunxi Han3, Weiling Chen1, Zhihui Li1.   

Abstract

Three-dimensional (3D) speckle-tracking echocardiography (STE) is a new imaging modality used for quantitative analysis of left ventricular (LV) function. The aim of this study is to assess the value of 3D STE in early detection of subclinical myocardial involvement in children with Duchenne muscular dystrophy (DMD). Fifty-six children with DMD (mean age, 8.8 ± 1.9 years) and 31 age-matched control subjects were studied. Patients were subdivided into two groups by age: ≤ 8 or > 8 years. Standard echocardiography examinations were performed to measure LV size and ejection fraction (EF). 3D STE was performed to assess LV 3D global strain and LV end-diastolic volume (EDV), end-systolic volume (ESV), and EF. Standard and 3D echocardiography measures were compared between children with DMD and those in the control group as well as between different patient groups. The areas under the receiver-operating characteristic (ROC) curve were calculated to determine the capability of 3D global strain indices to discriminate between patients and control subjects. No significant difference was detected in either LVEF derived from M-mode or 3D echocardiography between the two groups, and they were both within the normal range. Compared with control subjects, children with DMD had significantly reduced LV 3D global longitudinal strain (GLS; - 16.6 ± 4.7 vs. - 19.5 ± 3.7, p = 0.003), global circumferential strain (GCS; - 13.7 ± 2.9 vs. - 15.8 ± 2.6, p = 0.001), global radial strain (GRS; 42.5 ± 9.7 vs. 50.3 ± 10.4, p = 0.001), and global area strain (GAS; - 25.3 ± 4.9 vs. - 30.7 ± 4.1, p = 0.000). The older DMD children (age > 8 years) had lower GLS (- 15.1 ± 4.43 vs. - 18.6 ± 4.35, p < 0.05), GCS (- 12.8 ± 3.48 vs. - 14.8 ± 2.83, p < 0.001), GAS (- 23.8 ± 4.7 vs. - 29.0 ± 5.4, p < 0.001), and GRS (40.7 ± 8.8 vs. 47.3 ± 11.5, p < 0.05) than younger patients (age ≤ 8 years). The AUC of GAS was 0.80, and the cutoff value of - 29.5 had a sensitivity of 85.7% and a specificity of 71.0% for differentiating DMD patients from control. 3D speckle-tracking echocardiography is useful for detecting subclinical myocardial dysfunction and stratifying cardiomyopathy in children with DMD.

Entities:  

Keywords:  Area strain; Cardiomyopathy; Children; Duchenne muscular dystrophy; Three-dimensional speckle-tracking echocardiography

Mesh:

Year:  2018        PMID: 30105418     DOI: 10.1007/s10554-018-1436-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  4 in total

1.  Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance.

Authors:  Lilia Oreto; Gian Luca Vita; Giuseppe Mandraffino; Scipione Carerj; Maria Pia Calabrò; Roberta Manganaro; Maurizio Cusmà-Piccione; Maria Chiara Todaro; Maria Sframeli; Maria Cinquegrani; Antonio Toscano; Giuseppe Vita; Sonia Messina; Concetta Zito
Journal:  Acta Myol       Date:  2020-12-01

Review 2.  Anti-Remodeling Cardiac Therapy in Patients With Duchenne Muscular Dystrophy, Meta-Analysis Study.

Authors:  Bruria Hirsh Raccah; Bar Biton; Offer Amir; Israel Gotsman; Dean Nahman; Ilan Matok
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

Review 3.  Usefulness of speckle-tracking echocardiography for early detection in children with Duchenne muscular dystrophy: a meta-analysis and trial sequential analysis.

Authors:  Guang Song; Jing Zhang; Xin Wang; Xintong Zhang; Feifei Sun; Xiaona Yu
Journal:  Cardiovasc Ultrasound       Date:  2020-07-10       Impact factor: 2.062

4.  Evaluation of Left Ventricular Systolic Function in Patients with Coronary Microvascular Dysfunction by Three-Dimensional Speckle-Tracking Imaging.

Authors:  Ziheng Yu; Hongfen Pan; Zhenfeng Cheng; Kongjie Lu; Huanhuan Hu
Journal:  Braz J Cardiovasc Surg       Date:  2022-05-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.